by Katie Nightingale | Nov 24, 2022 | Myrovlytis Trust Blog
The first BHD Community Symposium was held on October 8th, 2022. We were delighted to have over 200 people registered from 22 countries across 5 continents for this virtual event. This year’s symposium was the first deliberately designed to be accessible to all...
by Katie Nightingale | Oct 19, 2022 | Myrovlytis Trust Blog
In September 2022, we attended the Immuno UK conference. Held over 2 days in London, UK, this conference brought together over 260 people from industry and academic research. We heard the latest updates in the field of “immune oncology”. This can be described as...
by Katie Nightingale | Oct 10, 2022 | Uncategorized
On 22nd November 2022, a mini-symposium “On Birt-Hogg-Dubé Syndrome and Folliculin” is being held in celebration of the PhD defenses of Irma van de Beek and Iris Glykofridis. The event will feature an update about the current and future BHD research taking place at...
by Katie Nightingale | Jul 12, 2022 | Myrovlytis Trust Blog
The 11th European Conference on Rare Diseases & Orphan Products 2022 was held from 27th June to 1st July. We were delighted to attend and present at this event focused on putting rare disease policy into action. Over 840 participants from 61 countries came...
by Katie Nightingale | May 9, 2022 | Myrovlytis Trust Blog
The Myrovlytis Trust is delighted to announce that registration and abstract submission for the virtual BHD Community Symposium 2022 is now open! Following the success of our research symposium in 2021, the Myrovlytis Trust and BHD Foundation are delighted to announce...
Recent Comments